Table 2 Characteristics of clinically apparent infections during the previous year
From: Sepsis-induced long-term immune paralysis – results of a descriptive, explorative study
Control (n = 8) | Sepsis (n = 8) | |
|---|---|---|
Individuals with ≥1 infection | 0 (0) | 5 (62.5) |
Incidence per annum, number (range) | 1 (0–5) | |
Outpatient | 2 (25) | |
Stationary | 2 (25) | |
Antibiotic therapy | 4 (50) | |
Application of blood components | 2 (25) | |
Site of infection | ||
Upper airway | 3 (37.5) | |
Lower airway | 2 (25) | |
Urogenital | 0 (0) | |
Gastrointestinal | 1 (12.5) | |
Central nervous | 0 (0) | |
Special infectious entities | ||
Herpes zoster | 1 (12.5) | |
Herpes simplex | 0 (0) | |
Oral candidiasis | 1 (12.5) | |
Cytomegalovirus (re)infection | 0 (0) |